AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18179308 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-Family Psychoeducation Groups (MFPGs), 8-session manual-driven treatment as an adjunct to current medications and psychotherapy.
Number of subjects: 165
Study 18179308 — intervention group
Group type: COMPARATOR
Intervention: Wait-list condition (control group), n=87, randomized into a 1-year wait-list condition.
Number of subjects: 165
Study 16306721 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia via an indwelling intrathecal catheter
Number of subjects: 60
Study 16306721 — intervention group
Group type: COMPARATOR
Intervention: High-dose intravenous opioid
Number of subjects: 60
Study 12407271 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive case management
Number of subjects: 225
Study 12407271 — intervention group
Group type: COMPARATOR
Intervention: Standard case management
Number of subjects: 225
Study 12799979 — intervention group
Group type: EXPERIMENTAL
Intervention: High self-efficacy and internal locus of control
Number of subjects: 56
Study 12799979 — intervention group
Group type: COMPARATOR
Intervention: Low self-efficacy and high external locus of control
Number of subjects: 56
Study 7993925 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation program (8-week ambulatory rehabilitation)
Number of subjects: 32
Study 7993925 — intervention group
Group type: COMPARATOR
Intervention: Control group (NR-group) aged < or = 65
Number of subjects: 32
Study 7993925 — intervention group
Group type: COMPARATOR
Intervention: Control group (NR-group) aged > 65
Number of subjects: 32
Study 3177586 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous vision bifocal contact lenses
Number of subjects: 10
Study 3177586 — intervention group
Group type: COMPARATOR
Intervention: Monovision
Number of subjects: 10
Study 3177586 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifocal stereopsis with best near over-refraction
Number of subjects: 10
Study 30574864 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination (FDC) of gemigliptin 50 mg and metformin 500 mg
Number of subjects: 28
Study 30574864 — intervention group
Group type: COMPARATOR
Intervention: Loose combination of gemigliptin 50 mg and metformin 500 mg
Number of subjects: 28
Study 7448102 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical extradural analgesia using 2% mepivacaine
Number of subjects: 0
Study 7448102 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic extradural analgesia using 2% mepivacaine
Number of subjects: 0
Study 7448102 — intervention group
Group type: EXPERIMENTAL
Intervention: Both cervical and thoracic extradural analgesia
Number of subjects: 0
Study 30664989 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab (1200 mg intravenously every 3 weeks)
Number of subjects: 73
Study 30664989 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (up to 6 cycles of topotecan or re-induction of initial chemotherapy)
Number of subjects: 73
Study 28387891 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine butylbromide (intramuscular injection before operation)
Number of subjects: 142
Study 28387891 — intervention group
Group type: COMPARATOR
Intervention: No preoperative intramuscular injection (control group)
Number of subjects: 142
Study 26451155 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular Acupuncture (AA)
Number of subjects: 12
Study 26451155 — intervention group
Group type: COMPARATOR
Intervention: Sham Auricular Acupuncture (SAA)
Number of subjects: 12
Study 24102102 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine with a nonmydriatic camera
Number of subjects: 567
Study 24102102 — intervention group
Group type: COMPARATOR
Intervention: Traditional surveillance with an eye care provider
Number of subjects: 567
Study 24102102 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine group
Number of subjects: 567
Study 24102102 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall prevalence of diabetic retinopathy
Number of subjects: 567
Study 24102102 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall prevalence of macular edema
Number of subjects: 567
Study 21896093 — intervention group
Group type: EXPERIMENTAL
Intervention: VFR children
Number of subjects: 698
Study 21896093 — intervention group
Group type: COMPARATOR
Intervention: Non-VFR (tourist) children
Number of subjects: 698
Study 19706089 — intervention group
Group type: EXPERIMENTAL
Intervention: pimecrolimus 1% cream plus microdermabrasion
Number of subjects: 65
Study 19706089 — intervention group
Group type: COMPARATOR
Intervention: pimecrolimus 1% cream alone
Number of subjects: 65
Study 19706089 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 65
Study 18354887 — intervention group
Group type: EXPERIMENTAL
Intervention: Directional microphones
Number of subjects: 57
Study 18354887 — intervention group
Group type: COMPARATOR
Intervention: Omni-directional microphones
Number of subjects: 57
Study 18354887 — intervention group
Group type: COMPARATOR
Intervention: Toggle-switch equipped amplification
Number of subjects: 57
Study 18354887 — intervention group
Group type: COMPARATOR
Intervention: Unaided group
Number of subjects: 57
Study 15561650 — intervention group
Group type: EXPERIMENTAL
Intervention: MTZ/CTX 1 g once daily
Number of subjects: 70
Study 15561650 — intervention group
Group type: COMPARATOR
Intervention: T/C 3.1 g every 6 hours
Number of subjects: 70
Study 11557914 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine 2 mg
Number of subjects: 20
Study 11557914 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine 4 mg
Number of subjects: 20
Study 11557914 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine 6 mg
Number of subjects: 20
Study 11557914 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine 6 mg with 200 mg ketoconazole
Number of subjects: 20
Study 11557914 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9631989 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 150 mg once weekly
Number of subjects: 362
Study 9631989 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 300 mg once weekly
Number of subjects: 362
Study 9631989 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 450 mg once weekly
Number of subjects: 362
Study 9631989 — intervention group
Group type: COMPARATOR
Intervention: Placebo once weekly
Number of subjects: 362
Study 7821469 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic anti-fibrinolytics
Number of subjects: 0
Study 7821469 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 3189489 — intervention group
Group type: EXPERIMENTAL
Intervention: Purposeful activity
Number of subjects: 30
Study 3189489 — intervention group
Group type: COMPARATOR
Intervention: Nonpurposeful activity
Number of subjects: 30
Study 30727715 — intervention group
Group type: EXPERIMENTAL
Intervention: Information system intervention for nursing staff with individual performance feedback
Number of subjects: 977
Study 30727715 — intervention group
Group type: COMPARATOR
Intervention: Control group with only global results feedback
Number of subjects: 977
Study 28941842 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold cabbage leaves
Number of subjects: 227
Study 28941842 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold gel packs
Number of subjects: 227
Study 28941842 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 227
Study 26939316 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy of acupoint application of jieyu plaster and acupuncture
Number of subjects: 86
Study 26939316 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 86
Study 26939316 — intervention group
Group type: COMPARATOR
Intervention: Acupoint application of jieyu plaster
Number of subjects: 86
Study 26939316 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy
Number of subjects: 86
Study 24148164 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet high in vegetables, fruits, and grains with intensive nutritional and behavior education
Number of subjects: 700
Study 24148164 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 700
Study 22105823 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid (video and workbook) for discussing terminal prognosis
Number of subjects: 0
Study 22105823 — intervention group
Group type: COMPARATOR
Intervention: Control arm (how cancer pain can be controlled)
Number of subjects: 0
Study 19749461 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin-based chemotherapy (exact dosage not specified)
Number of subjects: 57
Study 16569254 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 290
Study 16569254 — intervention group
Group type: COMPARATOR
Intervention: Bi-level Positive Airway Pressure (BiPAP)
Number of subjects: 290
Study 12663292 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-folate diet (120 microg/d) for 7 weeks
Number of subjects: 33
Study 12663292 — intervention group
Group type: EXPERIMENTAL
Intervention: Folate repletion with 400 microg/d for 7 weeks
Number of subjects: 33
Study 12663292 — intervention group
Group type: EXPERIMENTAL
Intervention: Folate repletion with 400 microg/d
Number of subjects: 33
Study 10363732 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthrotec 75 (diclofenac sodium 75 mg-misoprostol 200 microg) administered twice daily
Number of subjects: 1203
Study 10363732 — intervention group
Group type: COMPARATOR
Intervention: nabumetone 1500 mg administered once daily
Number of subjects: 1203
Study 10363732 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthrotec 75
Number of subjects: 1203
Study 10363732 — intervention group
Group type: COMPARATOR
Intervention: nabumetone
Number of subjects: 1203
Study 8545563 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (V)
Number of subjects: 30
Study 8545563 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (E)
Number of subjects: 30
Study 8545563 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil + Enalapril (V+E)
Number of subjects: 30
Study 1952710 — intervention group
Group type: EXPERIMENTAL
Intervention: Tixocortol-neomycin combination (Pivalone-Neomycin nasal suspension)
Number of subjects: 211
Study 1952710 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle: N‐cetylpyridinium chloride, sodium chloride, sodium hydroxide solution, benzyl alcohol, purified water, monosodium phosphate)
Number of subjects: 211
Study 6756484 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation training
Number of subjects: 21
Study 6756484 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation plus biofeedback‐aided relaxation
Number of subjects: 21
Study 6756484 — intervention group
Group type: COMPARATOR
Intervention: No‐treatment control group
Number of subjects: 21
Study 30888584 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol (4800 IU/daily)
Number of subjects: 58
Study 30888584 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 29980805 — intervention group
Group type: COMPARATOR
Intervention: Open clavicular hook plate (cHP) implantation (GI)
Number of subjects: 73
Study 29980805 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopically assisted double-suture-button (dDSB) implantation (GII)
Number of subjects: 73
Study 29980805 — intervention group
Group type: COMPARATOR
Intervention: Control group (GIII)
Number of subjects: 73
Study 26742487 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative immunosuppressive scheme (reduced cyclosporine dosage and substituted azathioprine for mycophenolate mofetil) in group 2
Number of subjects: 33
Study 26742487 — intervention group
Group type: COMPARATOR
Intervention: Initial immunosuppressive scheme (azathioprine, cyclosporine, and steroids) in group 1
Number of subjects: 33
Study 23681940 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproic acid (VPA) 10–20 mg/kg/day
Number of subjects: 33
Study 23681940 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 22506461 — intervention group
Group type: EXPERIMENTAL
Intervention: Discover cervical artificial disc replacement (CADR)
Number of subjects: 24
Study 22506461 — intervention group
Group type: COMPARATOR
Intervention: Anterior cervical decompression and fusion (ACDF)
Number of subjects: 24
Study 20363843 — intervention group
Group type: COMPARATOR
Intervention: Methacholine challenge with cutoff <or= 4 mg/mL
Number of subjects: 120
Study 20363843 — intervention group
Group type: COMPARATOR
Intervention: Methacholine challenge with cutoff <or= 16 mg/mL
Number of subjects: 120
Study 20363843 — intervention group
Group type: COMPARATOR
Intervention: Eucapnic voluntary hyperpnea (EVH) test
Number of subjects: 120
Study 18415773 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate 2 mL (Hyalgan 10.3 mg/mL)
Number of subjects: 251
Study 18415773 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological saline 20 mL (distention)
Number of subjects: 251
Study 18415773 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline 2 mL (placebo)
Number of subjects: 251
Study 18415773 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 251
Study 15778423 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranolazine with ketoconazole
Number of subjects: 0
Study 15778423 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranolazine with diltiazem
Number of subjects: 0
Study 15778423 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranolazine with simvastatin
Number of subjects: 0
Study 15778423 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranolazine in combination with diltiazem or simvastatin
Number of subjects: 0
Study 12444880 — intervention group
Group type: EXPERIMENTAL
Intervention: Back Performance Scale (BPS)
Number of subjects: 288
Study 10622010 — intervention group
Group type: EXPERIMENTAL
Intervention: Male patients
Number of subjects: 0
Study 10622010 — intervention group
Group type: EXPERIMENTAL
Intervention: Female patients
Number of subjects: 0
Study 10622010 — intervention group
Group type: EXPERIMENTAL
Intervention: GPs with a pessimistic view of depression
Number of subjects: 0
Study 10622010 — intervention group
Group type: EXPERIMENTAL
Intervention: Most severe vignette
Number of subjects: 0
Study 7540705 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg beta-sitosterol three times per day
Number of subjects: 200
Study 7540705 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 1781562 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg CD p.o. on the evening before the operation, followed by 25 mg p.o. in the morning
Number of subjects: 108
Study 1781562 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg F p.o. on the evening before the operation, followed by 1 mg p.o. in the morning
Number of subjects: 108
Study 1781562 — intervention group
Group type: COMPARATOR
Intervention: No premedication
Number of subjects: 108
Study 7004995 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid therapy
Number of subjects: 77
Study 7004995 — intervention group
Group type: COMPARATOR
Intervention: Control group (no corticosteroid therapy)
Number of subjects: 77
Study 31563396 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable, accelerometer‐based hip navigation system
Number of subjects: 110
Study 31563396 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgical technique
Number of subjects: 110
Study 31567988 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture treatment
Number of subjects: 36
Study 31567988 — intervention group
Group type: COMPARATOR
Intervention: Sham electroacupuncture treatment
Number of subjects: 36
Study 28595610 — intervention group
Group type: EXPERIMENTAL
Intervention: Danggui‐Sayuk‐Ga‐Osuyu‐Saenggang‐tang (DSGOST)
Number of subjects: 66
Study 28595610 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 27117175 — intervention group
Group type: EXPERIMENTAL
Intervention: Study Group (SG, circulating the prime with 40 g albumin for 5 minutes before CPB)
Number of subjects: 60
Study 27117175 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG, receiving 40 g human albumin 5 minutes after the initiation of CPB)
Number of subjects: 60
Study 27117175 — intervention group
Group type: EXPERIMENTAL
Intervention: Study Group (SG)
Number of subjects: 60
Study 27117175 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 60
Study 24976416 — intervention group
Group type: EXPERIMENTAL
Intervention: Skimmed milk (500 mL/d) for 1 year
Number of subjects: 161
Study 24976416 — intervention group
Group type: COMPARATOR
Intervention: Semi-skimmed milk (500 mL/d) for 1 year
Number of subjects: 161
Study 21750118 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic adjuvant radiotherapy
Number of subjects: 83
Study 21750118 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 83
Study 19770669 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin/ezetimibe (10 mg simvastatin and 10 mg ezetimibe, once a day)
Number of subjects: 23
Study 19770669 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (80 mg, once a day)
Number of subjects: 23
Study 16488405 — intervention group
Group type: EXPERIMENTAL
Intervention: Symbolic number magnitude processing (comparing Arabic digits)
Number of subjects: 90
Study 16488405 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-symbolic number magnitude processing (comparing collections)
Number of subjects: 90
Study 16488405 — intervention group
Group type: EXPERIMENTAL
Intervention: Processing physical size of Arabic digits in a Stroop paradigm
Number of subjects: 90
Study 16488405 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between MD and MD/RD children
Number of subjects: 90
Study 16488405 — intervention group
Group type: COMPARATOR
Intervention: Control group (normally achieving peers)
Number of subjects: 90
Study 15574665 — intervention group
Group type: EXPERIMENTAL
Intervention: Groups with high entitativity presenting strong arguments
Number of subjects: 0
Study 15574665 — intervention group
Group type: COMPARATOR
Intervention: Groups with high entitativity presenting weak arguments
Number of subjects: 0
Study 15574665 — intervention group
Group type: COMPARATOR
Intervention: Groups with low entitativity presenting strong arguments
Number of subjects: 0
Study 15574665 — intervention group
Group type: COMPARATOR
Intervention: Groups with low entitativity presenting weak arguments
Number of subjects: 0
Study 12119507 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisolone (PSL) >12.5 mg/day for at least 1 year
Number of subjects: 100
Study 12119507 — intervention group
Group type: COMPARATOR
Intervention: Inhaled corticosteroid (BDP) alone
Number of subjects: 100
Study 9987628 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipivefrin 0.1%
Number of subjects: 12
Study 9987628 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine 2%
Number of subjects: 12
Study 9987628 — intervention group
Group type: COMPARATOR
Intervention: Saline 0.9%
Number of subjects: 12
Study 1443881 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (0.25 mg)
Number of subjects: 6
Study 1443881 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 4061902 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine, 1.5 mg/kg
Number of subjects: 100
Study 4061902 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 100
Study 30306439 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP
Number of subjects: 41
Study 30317384 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheel-shaped composite cartilage graft (WsCCG)
Number of subjects: 90
Study 30317384 — intervention group
Group type: COMPARATOR
Intervention: Temporalis fascia (TF)
Number of subjects: 90
Study 30317384 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (WsCCG and TF)
Number of subjects: 90
Study 30317384 — intervention group
Group type: EXPERIMENTAL
Intervention: WsCCG
Number of subjects: 90
Study 27394404 — intervention group
Group type: EXPERIMENTAL
Intervention: Micafungin
Number of subjects: 250
Study 27394404 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole
Number of subjects: 250
Study 25515105 — intervention group
Group type: EXPERIMENTAL
Intervention: 62-hour total sleep deprivation
Number of subjects: 26
Study 25515105 — intervention group
Group type: COMPARATOR
Intervention: Control condition (rested)
Number of subjects: 26
Study 23904246 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D treatment
Number of subjects: 107
Study 23904246 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 20884302 — intervention group
Group type: EXPERIMENTAL
Intervention: eFlow rapid nebuliser
Number of subjects: 13
Study 20884302 — intervention group
Group type: COMPARATOR
Intervention: LC Plus nebuliser
Number of subjects: 13
Study 18797057 — intervention group
Group type: EXPERIMENTAL
Intervention: OMP + PUVA
Number of subjects: 86
Study 18797057 — intervention group
Group type: EXPERIMENTAL
Intervention: OMP + UVB (NB)
Number of subjects: 86
Study 18797057 — intervention group
Group type: EXPERIMENTAL
Intervention: OMP + UVB (BB)
Number of subjects: 86
Study 18797057 — intervention group
Group type: COMPARATOR
Intervention: OMP alone
Number of subjects: 86
Study 17166271 — intervention group
Group type: EXPERIMENTAL
Intervention: Training programme on diagnostic behaviour of clinicians
Number of subjects: 0
Study 12715373 — intervention group
Group type: COMPARATOR
Intervention: 6-8 cycles of CHOP
Number of subjects: 29
Study 12715373 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 cycles of CHOP and Dexa-BEAM followed by autologous hemopoietic cell transplantation with CBV or BEAM conditioning regimen
Number of subjects: 29
Study 16464208 — intervention group
Group type: EXPERIMENTAL
Intervention: Becaplermin gel (Regranex) plus good wound care (GWC)
Number of subjects: 314
Study 16464208 — intervention group
Group type: COMPARATOR
Intervention: GWC alone
Number of subjects: 314
Study 9146609 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 41
Study 9146609 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 7956719 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg single dose or 250 mg twice daily)
Number of subjects: 11
Study 7956719 — intervention group
Group type: COMPARATOR
Intervention: Midecamycin acetate (600 mg b.i.d.)
Number of subjects: 11
Study 7956719 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11